drugset / Trial / NCT00002653

Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma

NCT00002653

Phase 3 Unknown 1000 enrolled Medical Research Council
RandomizedTreatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. It is not yet known which combination chemotherapy regimen is most effective in treating older patients with multiple myeloma. PURPOSE: Randomized phase III trial to compare the effectiveness of combination chemotherapy with or without cyclophosphamide and prednisone in treating older patients with multiple myeloma.

Timeline

Start
1993-09
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Cyclophosphamide Other / unclassified Oral
Subject Doxorubicin Other / unclassified Intravenous
Subject Melphalan Small molecule Oral
Subject Prednisone Other / unclassified Oral
Subject carmustine Small molecule Intravenous

Indications